SCHEMBL1632121

SCHEMBL1632121

NS(=O)(=O)c1ccc(Nc2ncc3cccc(CNC4CCOCC4)c3n2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SYK P43405 2/20 0.45
▸ NTRK1 P04629 3/20 0.43
▸ TBK1 Q9UHD2 2/20 0.43
▸ IKBKE Q14164 1/20 0.43
▸ IKBKB O14920 2/20 0.43
▸ CA1 P00915 6/20 0.43
▸ CA2 P00918 6/20 0.43
▸ CA9 Q16790 6/20 0.43
▸ CA12 O43570 4/20 0.43
▸ CDK2 P24941 3/20 0.43
▸ CDK1 P06493 2/20 0.43
▸ CCNT1 O60563 1/20 0.43
▸ CCNB1 P14635 1/20 0.43
▸ CDK7 P50613 1/20 0.43
▸ CDK9 P50750 1/20 0.43
▸ CCNH P51946 1/20 0.43
▸ NUAK1 O60285 1/20 0.42
▸ STK16 O75716 1/20 0.42
▸ CSF1R P07333 1/20 0.42
▸ CSNK2A2 P19784 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1634500 0.90 SYK (0.49) SYKNTRK1IKBKBCA1CA2
SCHEMBL1632055 0.87 CCNE1 (0.46) SYKIKBKBCDK2CDK1CCNT1
SCHEMBL1632276 0.83 NTRK1 (0.42) SYKNTRK1TBK1IKBKEIKBKB
SCHEMBL1632397 0.82 TBK1 (0.57) NTRK1TBK1IKBKEIKBKBCA1
SCHEMBL1632901 0.80 SYK (0.51) SYKIKBKBCA1CA2CA9
SCHEMBL1632502 0.80 ALDH1A1 (0.46) SYKIKBKBCA1CA2CA9
SCHEMBL13498245 0.79 CDK2 (0.48) NTRK1IKBKBCA1CA2CA9
SCHEMBL1632503 0.78 CDK2 (0.46) SYKIKBKBCA1CA2CA9
SCHEMBL1632328 0.78 CA2 (0.50) NTRK1IKBKBCA1CA2CA9
SCHEMBL1633586 0.77 CA1 (0.51) SYKNTRK1IKBKBCA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 — — US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 — — US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 — — US disclosed
Send feedback